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Abstract
Background: Previous studies have shown that woman attending their first cervical screening or colposcopy
appointment experience negative emotions, primarily anxiety and fear. With the introduction of the Human
Papillomavirus (HPV) vaccine, it is unknown whether these emotions will have altered or whether the information
needs of vaccinated women will have changed. The objective of this study is to determine the knowledge,
understanding and concerns that young women have about HPV when attending colposcopy and whether their
information needs are met.
Methods: This is a qualitative study using semi-structured interviews which were audiotaped and transcribed. Data
was analysed thematically, with recruitment until data saturation was reached. Women born after 01/09/1990 and
attending colposcopy as a result of abnormal cytology were eligible to join the study. Recruitment took place in an
out-patient regional colposcopy clinic, Aberdeen, Scotland.
Results: Fifteen women were interviewed. The majority of participants had some knowledge and understanding of
HPV, cervical screening and colposcopy. Knowledge about the HPV vaccine was more limited; a third of participants
misunderstood the effectiveness of the vaccine believing that is provided complete protection, and were left
feeling that it had failed them. Some also felt that they were “test cases” for the vaccine.
Conclusion: With the introduction of the HPV vaccine, the information and support needs of young women attending
colposcopy are not fully met, leaving women with unanswered questions. With increasing numbers of vaccinated
women entering the screening programme, it is timely to review the information available to these women.
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Background
The development of HPV vaccination and the introduc-
tion of immunisation programmes promises the greatest
impact to date on the primary prevention of cervical
cancer and other HPV-related diseases [1]. Both licenced
vaccines are specific to high-risk HPV 16 and 18 [2, 3],
and with 30% of cervical cancers caused by other
high-risk HPV genotypes [4], there remains a role for
secondary prevention (such as cervical screening).
In Scotland, women born after 1/9/1990 have been
offered HPV immunisation in catch-up programmes
between the ages of 14 and 17 years or school-based
programmes at age 11 to 13 years [4, 5]. Prior to receiv-
ing the HPV vaccine, young women and their parents/
guardians receive an information booklet which provides
information on the vaccine and its role in preventing
cervical cancer. This states that the vaccine only protects
against two strains of HPV that can lead to cervical can-
cer, and stresses the importance of attending cervical
screening [6]. It is not known to what extent this infor-
mation is read or understood.
In Scotland, at the age of 20 years and 3months,
women are invited to attend for cervical screening [7]. A
national information leaflet is sent with the invitation
and includes information about the need for screening;
what happens during an appointment; the implications
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of an abnormal result; information on cervical cancer
and again states that even if they have received the
HPV vaccination, they should still attend regular cer-
vical screening [8]. Following screening, and as a re-
sult of abnormal cytology, some women will be
referred for colposcopy [8]. Local information leaflets
sent prior to colposcopy aim to inform women on
what to expect during their appointment and to pro-
vide information on their diagnosis of abnormal cell
changes [9].
Whilst information leaflets about screening and colpos-
copy have usually been developed with lay involvement,
there has been limited research into the information needs
of vaccinated women, and it is not clear whether their in-
formation needs are met by existing literature. As vacci-
nated women in Scotland are now being invited to attend
cervical screening (screening starts at age 20 [10]),
there is an opportunity to investigate whether vacci-
nated women have different concerns or information
needs. This study aims to address this gap in current
knowledge.
Methods
We conducted a semi-structured interview-based qualita-
tive study involving young women attending colposcopy.
Participants
All English-speaking women born after 1/9/1990 with
abnormal cervical cytology and who had been referred
to colposcopy at a regional colposcopy clinic were eli-
gible to take part. An invitation to participate in the
study was sent to them prior to their clinic visit. Women
were offered either a ‘face to face’ or a telephone inter-
view after their colposcopy visit.
Interviews
A topic guide was developed and piloted following a lit-
erature review [10–13] to explore women’s knowledge
and understanding around cervical screening, colpos-
copy and the HPV vaccine. The topic guide covered
areas such as knowledge and understanding of HPV, cer-
vical cancer, cervical screening, information received and
information needs. Sample questions included – ‘What
do you know about HPV?’, ‘How was your colposcopy
experience?’, ‘Was the information provided to you
helpful?’
Informed written consent was sought prior to inter-
view. Interviews were audio-recorded, transcribed verba-
tim and anonymised. All interviews took place after
participants had attended colposcopy. Participant char-
acteristics (HPV vaccination status, including type, num-
ber of doses and dates of delivery, and referral cytology)
were obtained from screening records held in the
Scottish Cervical Call Recall System (SCCRS).
Analysis
Analysis of transcripts started after the first participant
had been interviewed and continued throughout the
interview phase of the project. All transcripts were ana-
lysed thematically with themes and associated quotes
logged in a Microsoft Office Spreadsheet. To ensure
coding validity, three transcripts were coded separately
by two independent researchers and the main coding
structure was agreed upon. This coding was then applied
to all further transcripts. Any additional codes were
added as the analysis progressed. After 13 interviews, it
appeared that no new themes were emerging; two final
participants were interviewed to confirm data saturation.
Approvals
The study was sponsored by the University of Aberdeen.
Ethical approval was granted in writing by the North of
Scotland Research Ethics Committee (reference number
13/NS/0156). NHS Grampian provided R&D manage-
ment approval for the study.
Results
Forty-three women were identified as eligible to join this
study. Of these, 19 consented to take part and 15 were
interviewed. Three women agreed to telephone inter-
view but did not answer the telephone for the sched-
uled interview and one woman did not attend her
face-to-face interview.
Fifteen interviews were carried out between February
and March 2014: eight face-to-face and seven telephone
interviews. The mean length of interview was 18min
(range 15.5–22). The mean age of participants was 21.5
years (range 20–23 years). All participants were inter-
viewed within 9 days of colposcopy with the exception of
one who was interviewed 22 days later.
Of the 15 participants interviewed, 13 had received the
HPV vaccination and two were unvaccinated. The first
unvaccinated participant had not received the vaccine as
she lived abroad where the vaccine was unavailable; the
second completed her secondary education in 2008 and
did not take up the offer of vaccination from her Gen-
eral Practitioner. Two of the vaccinated participants
could not recall their immunisation status and a further
three could not correctly recall their number of received
doses – but this information was confirmed on SCCRS
for all participants.
Knowledge and understanding about HPV and cervical
cancer
All participants had heard of HPV. All participants iden-
tified that the majority of women are likely to be in-
fected at some time in their lives with a HPV infection
and stated that HPV is common - It’s [HPV] like a really,
really, really common infection that most people get once
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in a lifetime. Many participants (10 out of 15) were
aware that there are many different strains of HPV and
the majority of women discussed that HPV is a sexually
transmitted infection. Two participants were unable to
identify the mode of transmission of a HPV infection.
Participants discussed how a HPV infection was likely to
resolve spontaneously without intervention but some
‘stubborn’ cases may progress into abnormal cervical
cells.
Of the 15 participants interviewed, 13 could identify
that HPV was responsible for the change in cervical cells
that may lead to cervical cancer - Human Papillomavirus,
it can create cells which can become cancerous, it’s the na-
ture of the virus to cause cervical cancer. All participants
suggested that cervical cancer was common and more
likely to occur in younger women- It’s quite common in
the under 50’s anyway. It’s a cancer of younger people.
Knowledge and understanding about the HPV vaccination
Two thirds of participants (10/15) understood that the
vaccine did not protect against all strains of HPV, but
prevented against some types that cause cervical can-
cer - The vaccine is supposed to protect you against
certain strains of virus. It can’t protect you against all
the strains but against the main ones that cause cer-
vical cancer. The remaining five participants discussed
how they thought the vaccine provided them with
complete protection against all strains of HPV – I as-
sumed the vaccine would be 100%. I knew that it
technically wouldn’t be but I thought it would be like
99.999% effective. These five participants were asked
what they thought about the effectiveness of the vaccine
in light of their abnormal cytology and all expressed emo-
tions of disappointment and lack of confidence in the vac-
cine- The vaccine was a waste of time. I would say it’s
pointless and it’s not doing what it’s supposed to. Interest-
ingly, these five participants also expressed negative emo-
tions regarding their colposcopy experience.
When discussing HPV vaccination, one participant
expressed that she could not recall receiving any infor-
mation at the time of her vaccination or reading about it
in an information booklet – I don’t remember being in
school and being told this [vaccine] is 94% effective or
whatever. I don’t remember being told anything.
Rationalising an abnormal cytology
Considering the ten participants that acknowledged the
effectiveness of the HPV vaccine, only two women
understood that they were likely to be infected with a
type other than 16 and 18 -There are other strains that
cause cervical cancer. Because the vaccine only covers
two of the HPV infections. Just the big ones.
The other eight participants rationalised their abnormal
test result by creating assumptions about the vaccine.
Several participants suggested that they were the first
group of girls to receive the vaccine, and as a result, it
may not have been effective at the time -My year was the
first year […] Maybe it will improve in years to come. The
women who expressed these ideas were amongst the old-
est in the study and mentioned phrases such as ‘test group’
and ‘Guinea-pig group’.
Another participant suggested the original vaccine was
not effective and needed improvement. She mentioned
that other young women may assume they are com-
pletely protected against HPV by the original vaccine -
It’s different now. It’s been researched and changed. […] I
hope that other girls aren’t thinking ‘Well I’m fine be-
cause I’ve got it [vaccination]’. This participant may be
referring to the change in vaccine type used in the UK:
In 2012 the bivalent vaccine (protecting against HPV 16
and 18) was replaced with a quadrivalent vaccine, which
protects against HPV 6 and 11 (types which cause HPV
related genital warts) [14].
The majority of participants agreed that they would
still promote the HPV vaccine to young girls regardless
of their own experiences of HPV - I still think it’s worth-
while getting it [vaccine]. Obviously it wasn’t effective for
me but I wouldn’t change it looking back.
One participant reasonably suggested that she may
have already had a HPV infection prior to her vaccin-
ation - Well obviously it’s [vaccination] not been effective
for me but that’s probably because I might have had
HPV before it.
Information needs
Participants were asked whether the information leaflets
they received regarding HPV vaccination, cervical screen-
ing and colposcopy were useful or reassuring, and whether
they would recommend a change to the information.
Several women indicated that they read the leaflets but
were still unsure what to expect during a cervical
screening or colposcopy appointment: I don’t think any
of the booklets you get for your appointments are useful.
It doesn’t explain enough about what’s going on in depth.
If you’re going for something like that [colposcopy], you
want to know a lot more about it and understand every-
thing about. However, none of the woman identified any
specific additional information that could be included in
the screening or colposcopy leaflets.
In terms of improving the information leaflets, par-
ticularly the colposcopy information booklet, several
women suggested that the leaflet could be made more
attractive and more inviting to read- It’s very basic. It’s
not very interactive. The cervical screening book is [inter-
esting] but the colposcopy one wasn’t very interesting.
Three participants felt that the information they received
on HPV was lacking and they felt the need to undertake
their own research- Well I did do some research on it
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‘cause I didn’t know what it [HPV and abnormal cells]
was. I got my information probably the worst way, from
Google.
Several women thought information on HPV and cer-
vical screening should be introduced into school teaching
and television advertisements - Adverts on the TV and
then probably classes at school to teach more about it
[HPV infection]. More than they would have before.
Discussion
Main findings
This study has shown that most participants have a rea-
sonable understanding of HPV infection and cervical
cancer, but more limited understanding about the ef-
fectiveness of the HPV vaccine.
Strengths and limitations
We believe that this qualitative study is the first to ex-
plore the information needs of women who have been
vaccinated against HPV in a national catch-up programme
and been referred for colposcopy because of abnormal cy-
tology. Current information supplied in the national
programme in Scotland includes information for vacci-
nated women but was developed prior to vaccinated
women entering the programme. The results of this study
may be helpful in identifying areas where current informa-
tion for women may be improved.
All participants were interviewed after attending col-
poscopy and therefore had opportunity to discuss any is-
sues and gain information from the smear taker and/or
the colposcopist. This means that study participants
may be more knowledgeable or have different concerns
(having attended for colposcopy) than women who ei-
ther did not agree to participate in this study or who
defaulted from colposcopy. Women who default may
not read or understand the information they are sent
and, as a result, those who default from colposcopy
may have less understanding of HPV and cervical can-
cer than those that attend [15, 16]. Alternatively women
who have defaulted from colposcopy may have read the
information provided but failed to attend because they
feel falsely protected by the HPV vaccine [16, 17].
At the level of screening, however, this failure to at-
tend because of a false sense of protection from vaccin-
ation is not apparent: in Scotland, women who vaccinated
as part of the catch-up campaign are more likely to attend
for screening that those not vaccinated [18].
Interpretation
A systematic review of girls’ and parents’ information
needs regarding the HPV vaccination concluded that that
there is a limited understanding of HPV and the purpose
of the HPV vaccination [17]. Our study supports this find-
ing in women who were eligible for vaccination and are
now participating in cervical screening. Woman in our
study would have received timely information regarding
the HPV vaccination, cervical screening and colposcopy,
which states that the vaccine does not protect against all
HPV genotypes. Despite this, very few women had true
understanding regarding the HPV vaccination and their
underlying HPV infection. Two thirds of participants
understood that the vaccine could not protect against all
types of HPV, but only two participants had extrapo-
lated that they must have a HPV infection other than
types 16 or 18. This indicates that, at colposcopy, vacci-
nated women may need repetition or re-enforcement of
the information provided at vaccination and on enter-
ing screening. The remaining third of participants as-
sumed that they were unable to be infected with HPV
as a result of their vaccination. All of these women
expressed disappointment and lack of confidence in the
vaccine based on their perception that the vaccine was
ineffective. They also expressed a more negative re-
sponse to the colposcopy experience compared to the
other interviewees. It is possible that if they had they
more accurately understood the protection offered by
the vaccine that their negative experience of colposcopy
may have been alleviated, at least in part.
In addition to the written information women receive,
they will also have received verbal information from the
colpsocopist. Our results suggest that HPV-vaccinated
women referred to colposcopy may need different or sup-
plementary information about vaccination and screening
to target their concerns. This need for supplementary in-
formation may extend to vaccinated women invited for
cervical screening and young girls awaiting vaccination
[17], but we did not investigate this. Lack of knowledge
and understanding can be a barrier to attending for HPV
vaccination and colposcopy [1, 15, 19] and developing ap-
propriate materials may encourage attendance [17]. Many
commented that more women might read the colposcopy
leaflet if redesigned to appeal to young women. The local
colposcopy leaflet pre-dates the introduction of the
HPV vaccine and an update is timely; it may also be
timely to consider the development of national infor-
mation resources. Some participants suggested the use
of TV/radio advertisements, in addition to updated
leaflets, to share information HPV and cervical screen-
ing as not everyone will read the information provided.
Such campaigns have been successful elsewhere – for
example, during a mass-media campaign to promote at-
tendance for cervical screening in Australia, attendance
increased by 27% [20]. This was undertaken before vac-
cinated women entered the screening programme, and
it is not clear whether a similar effect would be seen in
vaccinated women, or in the UK. The role of television
and social media may be an interesting avenue for fur-
ther study.
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Several participants suggested that school teaching
would be the best way to inform girls about what to
expect when they attend cervical screening and the
limits of the HPV vaccine. A teaching intervention last-
ing 5–10min was shown to significantly increase the
knowledge of HPV infection and vaccination in young
men and women between the ages of 18–26, however
the study did not consider how well participants retained
the knowledge in the longer term [21]. Given that
screening will now start in Scotland at 25 years [22], the
length of time between any school-based education and
onset of screening may dilute any effect of the education
on screening attendance.
One concern expressed by a participant was that the
vaccine used in the UK national vaccination programme
had changed since she had received her immunisation. It
is not clear whether she was aware that the reason for
this was due to the tendering process for national pro-
curement in the UK national health system [14] rather
than for reasons of effectiveness. However, other women
also made comments suggesting that the vaccine had
been improved since they had received it. We do not
know whether the wider population are aware of the
change in vaccine; understand the reason for this change
or if there are wider held concerns about the vaccine
changes. Given that the UK contract for the vaccine was
re-tendered in 2016 [14] consideration might be given as
to how to communicate information about changes to the
vaccine offered within the HPV vaccination programme.
Recommendation for practice
As more vaccinated women enter the screening
programme, it is timely for cervical screening and col-
poscopy information leaflets to be reviewed. The up-
dated cervical screening information leaflets currently
used in Aberdeen Royal Infirmary, Scotland, can be viewed
by following the weblink, http://www.healthscotland.com/
documents/24327.aspx. Updated colposcopy information
leaflets are currently in progress.
For vaccinated women referred to colposcopy, explan-
ation as to the different types of HPV, and why they may
have an abnormal screening test, may lead to a more
positive colposcopy experience.
Conclusion
The information and support needs of young vacci-
nated women attending colposcopy are not fully met,
leaving women with unanswered questions particularly
around the effectiveness of the vaccine in relation to
their cervical abnormalities. With increasing numbers
of women entering the screening programme, it is
timely to review the information available to these
women.
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